# Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes

> **NCT01939834** · NA · TERMINATED · sponsor: **Sue Brown** · enrollment: 10 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** Overnight CLC
- **DEVICE:** Sensor-Augmented Pump Therapy (SAP)

## Key facts

- **NCT ID:** NCT01939834
- **Lead sponsor:** Sue Brown
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Subjects preferred the 5 night overnight system in terms of ease of use.
- **Last updated:** 2024-05-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01939834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01939834, "Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01939834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*